Denver, CO (PRWEB) February 29, 2016
In honor of Brain Injury Awareness Month, CereScan, the nation’s leader in providing statistically measured brain diagnostics, is taking steps to increase awareness about brain injuries by offering a discounted comprehensive brain diagnostic package to patients.
During the month of March, CereScan will offer free qEEG (Quantitative Electroencephalography) brain mapping – a $900 value --- with every qSPECT brain scan appointment at its metro Denver location. The company will also provide free brain injury consultations to those concerned about lingering symptoms from past concussions.
QEEG brain mapping is the latest diagnostic service to be offered by CereScan. In conjunction with the company’s qSPECT functional brain imaging, the two procedures provide a comprehensive look into how the brain is functioning. While SPECT imaging measures perfusion patterns (bloodflow) and pinpoints problem areas below the cortex, qEEG measures cortical electrical activity by measuring brainwaves.
“CereScan’s commitment to furthering awareness and providing hope to those suffering from traumatic brain injuries is incredibly inspiring and strong,” says John Kelley, CEO of CereScan. “Finding an answer for the women and men fighting these invisible wounds should be a priority every day of the year.”
Each year, nearly 1.7 million emergency department visits, hospitalizations or deaths are associated with traumatic brain injury, according to the Centers for Disease Control and Prevention (CDC). However, due to varying definitions and possible under-reporting, the exact rate at which concussions or mild traumatic brain injuries (TBIs) happen annually in the United States is not accurately known. CDC experts estimate as many as 3.8 million sports and recreation-related TBIs occur every year.
Traumatic brain injuries can affect the functionality of the brain and many times lead to psychological issues, such as nervousness, irritability, depression and mood swings. Due to the variety of symptoms that can result from a TBI, the condition is commonly misdiagnosed.
That’s where CereScan can make all the difference. CereScan’s qSPECT imaging technology goes beyond traditional diagnostic tools to review cerebral blood flow and cellular processes that help accurately diagnose traumatic brain injuries, helping physicians and patients create an effective treatment plan.
The company has been on the front lines in the identification and treatment of TBI through its Invisible Brain Injury Project in partnership with the Tug McGraw Foundation. In the study, CereScan first helped former military members assess the extent of their brain injury and then determine the efficacy of a new therapy by providing pre- and post-measurements and statistical analysis.
CereScan joins the Tug McGraw Foundation and the Colorado Neurological Institute to promote awareness about brain injury prevention, recognition and response. To find out more about how you can support these organizations dedicated to enhancing the lives of those affected by brain injuries, visit TugMcGraw.org or TheCNI.org.
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and qSPECT (Quantitative Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:
- Traumatic Brain Injury
- Toxic Brain Injury
- Alzheimer’s Disease
- Mild Cognitive Impairment
- Other Dementias
- Parkinson’s Disease
- Obsessive Compulsive Disorder
- Bipolar Disorder
- Anxiety Disorder
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.